Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease
With Klinic's online platform, there's no need for an in-person visit
Prescription GLP-1 medications the ones youve heard about in the news work by directly mimicking this hormone
Contaminant screening The company claims screening for heavy metals, microbials, and common contaminants
Adv Ther 42 , 49935009 (2025)
Clearing Up Common Misconceptions "Side effects mean it's working." Trial data from STEP-1 and STEP-3 do not support a correlation between GI side effect intensity and weight loss response